| 000 | 00796nam a22002532 4500 | ||
|---|---|---|---|
| 001 | hsl001008170 | ||
| 003 | DGPO | ||
| 005 | 20170826152610.0 | ||
| 008 | 170124s1973 dcu f000 0 eng d | ||
| 040 |
_aGPO _cGPO _dMvI |
||
| 074 | _a0507-G-02 | ||
| 086 | 0 | _aHE 20.3168/3:T 68 | |
| 099 | _aHE 20.3168/3:T 68 | ||
| 245 | 0 | 0 | _aObjective 3, develop means to prevent transformation of normal cells to cells capable of forming cancers. |
| 260 |
_a[Washington, D.C., _c1973] |
||
| 300 | _a[370] p. | ||
| 490 | 0 | _aNational cancer program | |
| 500 | _a(DHEW publication (NIH) 74-586.). | ||
| 500 | _a4to. | ||
| 500 | _aDistribution made by issuing office. | ||
| 500 | _aCRDP Program Historic Shelflist record. | ||
| 650 | 0 |
_aCancer _xResearch. |
|
| 710 | 2 | _aNational Cancer Institute (U.S.) | |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c264999 _d264999 |
||